References
- Moore JG. Benign diseases of the uterus. In: Hacker NF, Moore JG, eds. Essentials of obstetrics and gynecology. 1st ed. Philadelphia: Saunders, 1986: 272–6
- Lacey CG. Benign disorders of the uterine corpus. In: Pernoll ML, ed. Current obstetric and gynecologic diagnosis and treatment. 7th ed. Norwalk, Conn: Appleton & Lange, 1991: 732–8
- Wallach EE. Myomectomy. In: Thompson JD, Rock JA, eds. Te Lindes operative gynecology. 7th ed. Philadelphia: Lippincott, 1992: 647–53
- Moghissi KS. Hormonal therapy before surgical treatment for uterine leiomyomas. Surg Gynecol Obstet 1991; 172(6): 497–502
- Weingold AB. Pelvic mass. In: Kase NG, Weingold AB, Gershenson DM, eds. Principles and practice of clinical gynecology. 2d ed. New York: Churchill Livingstone, 1990: 551
- Friedman AJ, Hoffman DI, Comite F, et al. Treatment of leiomyomata uteri with leuprolide acetate depot: a double-blind, placebo-controlled, multicenter study. Obstet Gynecol 1991; 77(5):720–5
- McCarthy S. New imaging techniques in gynecology. In: Thompson, Rock, eds,3 pp 281–3
- Moghissi KS. Clinical applications of gonadotropin-releasing hormones in reproductive disorders. Endocrinol Metab Clin North Am 1992; 21(1): 125–40
- Nakamura Y, Yoshimura Y, Yamada H, et al. Treatment of uterine leiomyomata with a luteinizing hormone-releasing hormone agonist: the possibility of nonsurgical management in selected perimenopausal women. Fertil Steril 1991; 55(5): 900–5
- Stovall TG, Ling FW, Henry LC, et al. A randomized trial evaluating leuprolide acetate before hysterectomy as treatment for leiomyomas. Am J Obstet Gynecol 1991; 164(6 Pt 1): 1420–5